Watchlist Price Alert

Vanda Pharmaceuticals Inc... (VNDA)

NASDAQ: VNDA · Real-Time Price · USD

4.97

0.08 (1.64%)

At close: Jul 03, 2025, 1:04 PM

5.02

1.01%

After-hours: Jul 03, 2025, 01:04 PM EDT

1.64% (1D)

Bid	4.95
Market Cap	292.9M
Revenue (ttm)	201.35M
Net Income (ttm)	-44.25M
EPS (ttm)	-0.76
PE Ratio (ttm)	-6.54
Forward PE	-12.54
Analyst	Strong Buy

Ask	5.04
Volume	293,730
Avg. Volume (20D)	503,642
Open	4.90
Previous Close	4.89
Day's Range	4.86 - 5.04
52-Week Range	3.81 - 6.37
Beta	0.67

About VNDA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VNDA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VNDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

8 months ago

+8.33%

Vanda Pharmaceuticals shares are trading higher af... Unlock content with Pro Subscription

News

1 week ago · youtube.com

Risks of a blockade in the Strait of Hormuz 'remain absolutely minimalistic': Vanda Insights

Vandana Hari of Vanda Insights discusses oil price reaction to the U.S. strikes on Iran's nuclear facilities, as well as the likelihood of a potential closure in the Strait of Hormuz.

1 month ago · seekingalpha.com

Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA ) Q1 2025 Results Conference Call May 7, 2025 4:30 PM ET Company Participants Kevin Moran - CFO Mihael Polymeropoulos - President, Chairman and CEO Tim Williams...

1 month ago · zacks.com

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates

Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.07 per share a year ago.